Agios Pharmaceuticals Inc. (8AP)
FSX
Real-time Data
06:00 AM
Day's Range
28.4052 wk Range
19.70Overview - 8AP - Agios Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
947.62M
P/E (Trailing)
‪3.80‬
P/E (Forward)
‪-3.93‬
PEG Ratio
‪-0.30‬
Price / Sales (TTM)
‪17.24‬
Price / Book
‪1.92‬
EV / EBITDA
‪-2.44‬
Profitability
Gross Margin
‪93.30%‬
Profit Margin
‪88.25%‬
Operating Margin
‪-247.07%‬
Return on Assets
‪-22.24%‬
Return on Equity
‪-34.33%‬
Ownership
Shares Outstanding
59.60M
Float
50.01M
Held by Insiders
‪1.06%‬
Held by Institutions
‪112.34%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪30.79‬
200-Day Avg
‪25.87‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 8AP - Agios Pharmaceuticals Inc.
Peers - 8AP - Agios Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 8APFSXAgios Pharmaceuticals Inc.1.77BMarket Cap-14.79%52-week change3.80P/E (Trailing)‪88.25%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.38P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 8AP - Agios Pharmaceuticals Inc.
About
Agios Pharmaceuticals Inc. is a biopharmaceutical company specializing in cellular metabolism to develop differentiated medicines for rare diseases, with a particular emphasis on classical hematology. The company focuses on creating potentially transformative small-molecule therapies targeting unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
